Inherited parental methylation shifts over time, may have functional effects in the brain and other tissues

Image of mouse cerebellum section with cells having different imprinted methylation

In this image of a mouse cerebellum section, the cells exhibiting different imprinted methylation.

Image: Courtesy of Cell Press

September 20, 2016

Tags: Jaenisch LabGenetics + Genomics

CAMBRIDGE, Mass.  – Parental imprinting—a form of gene control passed down from parents to offspring—is far more dynamic than previously thought and may contribute to changes in the brain and other tissues over time. This finding by Whitehead Institute scientists challenges current understandings of gene regulation via DNA methylation, from development through adulthood. 

“All of this dynamic variation between individuals and within individuals is really very surprising,” says Whitehead Founding Member Rudolf Jaenisch, who is also a professor of biology at MIT. “We don’t yet understand the significance of this. Is it functionally important and does it reflect, particularly in the brain, the history of neurons—activity states, for example? These are all interesting possibilities.”

Methylation—the attachment of molecules, known as methyl groups, to DNA—is an epigenetic phenomenon that affects gene expression. Generally, methylated genes are turned off while unmethylated genes are active and ready for transcription. Although advances in sequencing technology have yielded informative methylation maps in a variety of tissues, such approaches only capture static “snapshots” of methylation and are unable to reveal the dynamics of methylation in real time in tissues and individual cells.

Because of this limitation, researchers have theorized that inherited methylation, also referred to as parental imprinting, largely remains stable throughout development, except during two important developmental milestones: after fertilization and during the creation of sperm and egg cells. Altered gene imprinting at other times has been associated with developmental disorders and cancer.

To investigate active methylation in individual cells, Jaenisch lab postdoctoral researcher Yonatan Stelzer developed a reporter system that tracks genomic methylation in real-time and at single cell resolution. When a target gene is unmethylated, the reporter is also unmethylated, triggering expression of a glowing protein that illuminates the cell. When the target is methylated, so too is the reporter. The glowing protein is then unexpressed, leaving the cell dark. As the target gene’s methylation changes, so does the reporter’s.

In the latest research, described online this week in the journal Cell Reports, Stelzer used the reporter system in mice to discover that imprinted methylation in developing and adult tissues is actively regulated rather than merely maintained in stable fashion.

“What we see with the reporter in adult tissues is very surprising and much more complex than we had thought,” says Stelzer, who is a co-author of the Cell Reports paper. “The regulation of imprinted methylation results in these very consistent patterns in different tissues and even in a cell-type dependent manner. In the case of neural cells, it means that imprinted methylation is dynamically shaping the adult brain over time and could play a role in aging. Because this imprinting affects hundreds of genes that are non-coding, including microRNAs and non-coding RNAs, it’s a very interesting fine-tuning mechanism for the dosage of gene expression in the brain and elsewhere in the body.”

Although Stelzer notes that the results of his latest research are indeed exciting, they are just a beginning.

“Our work is the first observation of these changes,” he says. “Now we need to understand their functional consequences and the mechanism that regulates these changes in methylation.”

 

This work was supported by the National Institutes of Health (NIH grant HD 045022), the Human Frontier Science Program, and the Brain and Behavior Research Foundation (grant 22950). Jaenisch is an advisor to Stemgent and a cofounder of Fate Therapeutics and Fulcrum Therapeutics.

 

Written by Nicole Giese Rura

* * *

Rudolf Jaenisch's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology at Massachusetts Institute of Technology.

* * *

Full Citation:

“Parent-of-origin DNA methylation dynamics during mouse development”

Cell Reports, online September 20, 2016.

Yonatan Stelzer (1), Hao Wu (1), Yuelin Song (1,2), Chikdu Shivalila (1,2), Styliani Markoulaki (1), and Rudolf Jaenisch (1,2).

1. Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA

2. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA

Whitehead Institute is a world-renowned non-profit research institution dedicated to improving human health through basic biomedical research.
Wholly independent in its governance, finances, and research programs, Whitehead shares a close affiliation with Massachusetts Institute of Technology
through its faculty, who hold joint MIT appointments.

© Whitehead Institute for Biomedical Research              455 Main Street          Cambridge, MA 02142